Cyclacel Pharmaceuticals (CYCC)
(Delayed Data from NSDQ)
$1.51 USD
-0.09 (-5.63%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $1.52 +0.01 (0.66%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -5.92 |
EPS Last Quarter | -6.23 |
Last EPS Surprise | 1.89% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -18.70 |
Next Year | -3.24 |
EPS (TTM) | -27.22 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.37M | 0.42M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -5.92 | -5.98 | -18.70 | -3.24 |
# of Estimates | 1 | 1 | 2 | 1 |
Most Recent Consensus | -5.92 | -5.98 | -24.02 | -3.24 |
High Estimate | -5.92 | -5.98 | -13.38 | -3.24 |
Low Estimate | -5.92 | -5.98 | -24.02 | -3.24 |
Year ago EPS | -7.05 | -6.60 | -26.75 | -18.70 |
Year over Year Growth Est. | 16.03% | 9.39% | 30.09% | 82.67% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -5.92 | -5.98 | -18.70 | -3.24 |
7 Days Ago | -5.92 | -5.98 | -18.70 | -3.24 |
30 Days Ago | -5.92 | -5.98 | -18.70 | -3.24 |
60 Days Ago | -5.92 | -5.98 | -15.67 | -76.36 |
90 Days Ago | -5.92 | -5.98 | -15.67 | -76.36 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -5.92 | -5.98 | -18.70 | -3.24 |
Zacks Consensus Estimate | -5.92 | -5.98 | -18.70 | -3.24 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -6.23 | -7.35 | -6.60 | -7.05 | NA |
Estimate | -6.35 | -5.70 | -8.10 | -10.19 | NA |
Difference | 0.12 | -1.65 | 1.50 | 3.14 | 0.78 |
Surprise | 1.89% | -28.95% | 18.52% | 30.88% | 5.59% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more